209 related articles for article (PubMed ID: 25774666)
1. Unraveling the Link Between Ectodermal Disorders and Primary Immunodeficiencies.
D'Assante R; Fusco A; Palamaro L; Giardino G; Gallo V; Cirillo E; Pignata C
Int Rev Immunol; 2016; 35(1):25-38. PubMed ID: 25774666
[TBL] [Abstract][Full Text] [Related]
2. Human clinical phenotype associated with FOXN1 mutations.
Pignata C; Fusco A; Amorosi S
Adv Exp Med Biol; 2009; 665():195-206. PubMed ID: 20429426
[TBL] [Abstract][Full Text] [Related]
3. From murine to human nude/SCID: the thymus, T-cell development and the missing link.
Romano R; Palamaro L; Fusco A; Iannace L; Maio S; Vigliano I; Giardino G; Pignata C
Clin Dev Immunol; 2012; 2012():467101. PubMed ID: 22474479
[TBL] [Abstract][Full Text] [Related]
4. Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).
Lee WI; Huang JL; Yeh KW; Jaing TH; Lin TY; Huang YC; Chiu CH
J Formos Med Assoc; 2011 Dec; 110(12):750-8. PubMed ID: 22248828
[TBL] [Abstract][Full Text] [Related]
5. T-Cell Immunodeficiencies With Congenital Alterations of Thymic Development: Genes Implicated and Differential Immunological and Clinical Features.
Giardino G; Borzacchiello C; De Luca M; Romano R; Prencipe R; Cirillo E; Pignata C
Front Immunol; 2020; 11():1837. PubMed ID: 32922396
[TBL] [Abstract][Full Text] [Related]
6. Primary Immunodeficiencies with Elevated IgE.
Mogensen TH
Int Rev Immunol; 2016; 35(1):39-56. PubMed ID: 25970001
[TBL] [Abstract][Full Text] [Related]
7. FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches.
Gallo V; Cirillo E; Giardino G; Pignata C
J Clin Immunol; 2017 Nov; 37(8):751-758. PubMed ID: 28932937
[TBL] [Abstract][Full Text] [Related]
8. Thymus microenvironment in human primary immunodeficiency diseases.
Poliani PL; Vermi W; Facchetti F
Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):489-95. PubMed ID: 19841578
[TBL] [Abstract][Full Text] [Related]
9. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.
Orange JS; Levy O; Brodeur SR; Krzewski K; Roy RM; Niemela JE; Fleisher TA; Bonilla FA; Geha RS
J Allergy Clin Immunol; 2004 Sep; 114(3):650-6. PubMed ID: 15356572
[TBL] [Abstract][Full Text] [Related]
10. Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency.
Dupuis-Girod S; Cancrini C; Le Deist F; Palma P; Bodemer C; Puel A; Livadiotti S; Picard C; Bossuyt X; Rossi P; Fischer A; Casanova JL
Pediatrics; 2006 Jul; 118(1):e205-11. PubMed ID: 16769798
[TBL] [Abstract][Full Text] [Related]
11. A lesson for unraveling complex aspects of novel immunodeficiencies from the human equivalent of the nude/SCID phenotype.
Pignata C
J Hematother Stem Cell Res; 2002 Apr; 11(2):409-14. PubMed ID: 11983112
[TBL] [Abstract][Full Text] [Related]
12. Thymic hypoplasia and T-cell deficiency in ectodermal dysplasia: case report and review of the literature.
Brooks EG; Klimpel GR; Vaidya SE; Keeney SE; Raimer S; Goldman AS; Schmalstieg FC
Clin Immunol Immunopathol; 1994 Apr; 71(1):44-52. PubMed ID: 8137558
[TBL] [Abstract][Full Text] [Related]
13. [Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8].
Alcántara-Montiel JC; Vega-Torres BI
Rev Alerg Mex; 2016; 63(4):385-396. PubMed ID: 27795219
[TBL] [Abstract][Full Text] [Related]
14. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.
Courtois G; Smahi A; Reichenbach J; Döffinger R; Cancrini C; Bonnet M; Puel A; Chable-Bessia C; Yamaoka S; Feinberg J; Dupuis-Girod S; Bodemer C; Livadiotti S; Novelli F; Rossi P; Fischer A; Israël A; Munnich A; Le Deist F; Casanova JL
J Clin Invest; 2003 Oct; 112(7):1108-15. PubMed ID: 14523047
[TBL] [Abstract][Full Text] [Related]
15. X-linked and autosomal recessive Hypohidrotic Ectodermal Dysplasia: genotypic-dental phenotypic findings.
Clauss F; Chassaing N; Smahi A; Vincent MC; Calvas P; Molla M; Lesot H; Alembik Y; Hadj-Rabia S; Bodemer C; Manière MC; Schmittbuhl M
Clin Genet; 2010 Sep; 78(3):257-66. PubMed ID: 20236127
[TBL] [Abstract][Full Text] [Related]
16. X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival.
Nishikomori R; Akutagawa H; Maruyama K; Nakata-Hizume M; Ohmori K; Mizuno K; Yachie A; Yasumi T; Kusunoki T; Heike T; Nakahata T
Blood; 2004 Jun; 103(12):4565-72. PubMed ID: 14726382
[TBL] [Abstract][Full Text] [Related]
17. FOXN1 in organ development and human diseases.
Palamaro L; Romano R; Fusco A; Giardino G; Gallo V; Pignata C
Int Rev Immunol; 2014 Mar; 33(2):83-93. PubMed ID: 24432845
[TBL] [Abstract][Full Text] [Related]
18. Inherited disorders of human Toll-like receptor signaling: immunological implications.
Ku CL; Yang K; Bustamante J; Puel A; von Bernuth H; Santos OF; Lawrence T; Chang HH; Al-Mousa H; Picard C; Casanova JL
Immunol Rev; 2005 Feb; 203():10-20. PubMed ID: 15661018
[TBL] [Abstract][Full Text] [Related]
19. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia.
Jain A; Ma CA; Liu S; Brown M; Cohen J; Strober W
Nat Immunol; 2001 Mar; 2(3):223-8. PubMed ID: 11224521
[TBL] [Abstract][Full Text] [Related]
20. FOXN1 mutation abrogates prenatal T-cell development in humans.
Vigliano I; Gorrese M; Fusco A; Vitiello L; Amorosi S; Panico L; Ursini MV; Calcagno G; Racioppi L; Del Vecchio L; Pignata C
J Med Genet; 2011 Jun; 48(6):413-6. PubMed ID: 21507891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
